The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 480.00
Ask: 490.00
Change: -5.00 (-1.02%)
Spread: 10.00 (2.083%)
Open: 490.00
High: 490.00
Low: 485.00
Prev. Close: 490.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Buyback Program and Director Dealing

22 Apr 2010 12:17

RNS Number : 6287K
BrainJuicer Group PLC
22 April 2010
 



 

 

 

Press Release

22 April 2010

 

 

 

BrainJuicer Group PLC

 ("BrainJuicer or "the Company")

 

 

Results of Buyback Program and Director Dealing

 

Further to the announcement made this morning the Company can confirm that it has today bought back 650,000 Ordinary Shares in the Company at a price of 165p per Ordinary Share (the "Buy-Back Shares").

 

The Company has purchased the Buy-Back Shares in order to satisfy future awards under the Company's Long Term Incentive Plan ("LTIP"), which is in the process of being established (subject to approval by shareholders at the Company's AGM). The Buy-Back Shares are initially being held in Treasury and will be transferred to an Employee Benefit Trust ("EBT").

 

In order to satisfy the purchase of the Buy-Back Shares, John Kearon, the Company's Chief Executive Officer and the Company's other major shareholder, Unilever UK Holdings Limited, have today each sold 325,000 Ordinary Shares and their new respective holdings are described below:

 

Shares sold

Price sold at

Total number of ordinary shares held post transaction

% of total issued share capital with voting rights

John Kearon

325,000

165p

5,210,164

42.1%

Unilever UK Holdings Limited

325,000

165p

4,558,643

36.8%

 

As at the date of this announcement, the Company's issued share capital consists of 13,033,201 ordinary shares with a nominal value of 1 pence each ("Ordinary Shares"). As a result of the above transactions the Company now currently holds 660,000 Ordinary Shares in Treasury.

 

Therefore, the total number of Ordinary Shares with voting rights is 12,373,201.

 

The above figure of 12,373,201 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

 

 

- Ends -

 

 

For further information, please contact:

BrainJuicer plc

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer

www.brainjuicer.com

 

Canaccord Adams Limited

Mark Williams / Henry Fitzgerald-O'Connor

Tel: +44 (0)20 7050 6500

www.canaccordadams.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSLLFLLSEIFFII
Date   Source Headline
16th Apr 20247:00 amRNSTrading Update
24th Jan 20247:00 amRNSTrading Update
12th Dec 202312:51 pmRNSPresentation via Investor Meet Company
6th Dec 20237:00 amRNSChange of Auditor
6th Dec 20237:00 amRNSInterim Results
24th Oct 20237:00 amRNSTrading Update
27th Sep 20236:00 pmRNSResult of AGM
27th Sep 20237:00 amRNSTrading Update
31st Aug 20237:00 amRNSAnnual Report and Notice of AGM
1st Aug 20237:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2023
31st Jul 20232:00 pmRNSPreliminary Results Presentation
13th Jul 20237:30 amRNSTrading update
30th Jun 20239:00 amRNSResolution of Complaint for Trademark Infringement
28th Jun 202311:00 amRNSHolding(s) in Company
3rd May 20233:15 pmRNSFurther re Result of General Meeting
21st Apr 202311:56 amRNSResult of General Meeting
13th Apr 20237:00 amRNSFurther re Requisitioned General Meeting
12th Apr 20237:00 amRNSTrading Update
5th Apr 202310:45 amRNSNotice of Trading Update
24th Mar 20234:00 pmRNSPosting of Circular and Notice of Requisitioned GM
24th Mar 20237:00 amRNSPosting of Circular and Notice of Requisitioned GM
7th Mar 20237:30 amRNSReceipt of Requisition Notice
28th Feb 202312:50 pmRNSCapital Markets Day
23rd Feb 20237:00 amRNSTrading Update
14th Feb 20237:00 amRNSCapital Markets Day
13th Jan 20232:00 pmRNSDirector/PDMR Shareholding
10th Jan 202310:30 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 20224:00 pmRNSDirector/PDMR Shareholding
13th Dec 20226:25 pmRNSDirector/PDMR Shareholding
6th Dec 20224:15 pmRNSDirectorate Change
30th Nov 20227:00 amRNSInterim Results
25th Oct 20227:00 amRNSTrading Update
28th Sep 20226:15 pmRNSResult of AGM
31st Aug 202211:00 amRNSNotice of AGM
31st Aug 20227:00 amRNSDirectorate Change
31st Aug 20227:00 amRNSReview of strategic options
30th Aug 20226:00 pmRNSTransaction in Own Shares
19th Aug 20228:55 amRNSTransaction in Own Shares
3rd Aug 20225:45 pmRNSTransaction in Own Shares
2nd Aug 20223:45 pmRNSTransaction in Own Shares
29th Jul 20229:30 amRNSTransaction in Own Shares
26th Jul 20226:24 pmRNSTransaction in Own Shares
19th Jul 20224:00 pmRNSHolding(s) in Company
19th Jul 20223:00 pmRNSTransaction in Own Shares
18th Jul 20224:30 pmRNSTransaction in Own Shares
15th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20227:00 amRNSShare Buyback Programme
12th Jul 20227:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2022
12th Jul 20227:00 amRNSQuarterly Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.